Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Category
Global or ExUS Equities - Industry Sector
Sponsor
Global X
Fund Family
Index
Solactive Genomics Index
Index Weighting
Active/Passive
Expense
0.50%
Inverse/Leveraged
IPO
Apr 10, 2019
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
2.20%
SMA50
11.79%
SMA200
21.01%
Return% 1Y
59.01%
Return% 3Y
6.17%
Return% 5Y
-10.59%
Return% 10Y
Return% SI
Flows% 1M
28.30%
Flows% 3M
35.15%
Flows% YTD
33.90%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
52
AUM
86.73M
NAV/sh
52W High
59.48 -5.73%
52W Low
34.04 64.72%
Volatility
3.27% 2.65%
ATR (14)
1.51
RSI (14)
58.86
Beta
1.17
Rel Volume
93.75
Avg Volume
19.86K
Volume
93,103
Perf Week
-4.69%
Perf Month
17.01%
Perf Quarter
27.72%
Perf Half Y
18.04%
Perf YTD
23.35%
Perf Year
58.39%
Perf 3Y
12.32%
Perf 5Y
-39.89%
Perf 10Y
-
Prev Close
56.65
Price
56.07
Change
-1.02%
Jun-20-25 11:56AM
11:56AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-24-25 07:14AM
07:14AM Loading…
07:14AM
Apr-23-25 05:45AM
Apr-20-25 11:28AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Mar-19-25 03:52PM
01:38PM Loading…
Jan-26-22 01:38PM
Jan-20-22 09:38AM
Jan-13-22 01:38PM
Nov-25-20 03:37PM
Aug-27-20 05:31PM
Jun-08-20 04:00AM
Jun-04-20 12:20PM
May-26-20 12:50PM
07:40AM
Jan-09-20 11:13AM
Dec-26-19 02:30PM
Dec-18-19 01:41PM
Dec-12-19 08:00AM
Dec-04-19 10:23PM
Nov-29-19 12:15PM
06:55PM Loading…
Nov-25-19 06:55PM
Nov-21-19 12:15PM
Oct-30-19 10:43AM
Oct-10-19 09:25AM
Sep-06-19 03:07PM
11:09AM
Sep-04-19 03:18PM
Aug-05-19 12:00PM
Aug-01-19 12:10PM
Jun-24-19 12:17PM
Jun-19-19 11:15AM
Apr-15-19 02:00PM
Apr-11-19 02:18PM
Apr-10-19 08:01AM
Apr-09-19 05:15PM
10:03AM
Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.